Cargando…
An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts
Cancer is a heterogeneous disease caused by diverse genomic alterations in oncogenes and tumor suppressor genes. Despite recent advances in high-throughput sequencing technologies and development of targeted therapies, novel cancer drug development is limited due to the high attrition rate from clin...
Autores principales: | Cho, Sung-Yup, Kang, Wonyoung, Han, Jee Yun, Min, Seoyeon, Kang, Jinjoo, Lee, Ahra, Kwon, Jee Young, Lee, Charles, Park, Hansoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757806/ https://www.ncbi.nlm.nih.gov/pubmed/26831452 http://dx.doi.org/10.14348/molcells.2016.2350 |
Ejemplares similares
-
Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts
por: Na, Deukchae, et al.
Publicado: (2021) -
Patient-derived xenografts as compatible models for precision oncology
por: Cho, Sung-Yup
Publicado: (2020) -
Integration and implementation of precision medicine in the multifaceted inflammatory bowel disease
por: Jagirdhar, Gowthami Sai Kogilathota, et al.
Publicado: (2023) -
Epigenetic Changes in Neurodegenerative Diseases
por: Kwon, Min Jee, et al.
Publicado: (2016) -
Advanced Xenograft Model with Cotransplantation of Patient-Derived Organoids and Endothelial Colony-Forming Cells for Precision Medicine
por: Kwon, Junhye, et al.
Publicado: (2021)